Last updated: March 2026
Dapoxetine (brand name Priligy) is the only selective serotonin reuptake inhibitor (SSRI) purpose-designed for on-demand use. Unlike daily SSRIs that require weeks to reach steady state, dapoxetine's short half-life (~1.3 hours) enables effective use when taken 1-3 hours before sexual activity — and clears within 24 hours. Approved in 50+ countries; not FDA-approved in the US.
Dapoxetine's efficacy for premature ejaculation hinges on its unique pharmacokinetic profile — designed specifically for acute on-demand use rather than chronic daily dosing.
Dapoxetine blocks the serotonin transporter (SERT) — the same mechanism as all SSRIs. By preventing serotonin reuptake in the synaptic cleft, it increases serotonergic neurotransmission. In the context of ejaculation control, increased serotonin activity in descending spinal pathways inhibits the ejaculatory reflex at the spinal cord level. This directly prolongs the time to ejaculation.
Dapoxetine reaches peak plasma concentration (Tmax) in approximately 1-2 hours after oral administration. Critically, its half-life is only ~1.3 hours — dramatically shorter than other SSRIs (paroxetine t½ = 21 hours, sertraline t½ = 26 hours). This rapid onset and clearance enables on-demand use without the hormonal, mood, and sexual side effects of chronic SSRI accumulation.
Because dapoxetine doesn't accumulate with daily use (by design — it's for on-demand dosing only), the risk of serotonin syndrome from steady-state accumulation is essentially zero when used as directed. However, combining dapoxetine with other serotonergic agents (MAOIs, SSRIs, triptans, tramadol) creates real serotonin syndrome risk and is contraindicated. The as-needed window is 1 dose per 24 hours maximum.
Intravaginal ejaculation latency time (IELT) is the clinical measure for premature ejaculation. Across multiple Phase 3 trials, dapoxetine 30mg increased median IELT approximately 2-3x from baseline, while 60mg increased it ~3x. In men with an IELT of ~1 minute at baseline, this translates to ~2-3 minutes median — a clinically meaningful improvement. Patient-reported satisfaction scores also improved significantly vs placebo.
Data from the large multinational Phase 3 trials submitted for regulatory approval worldwide.
Blood pressure monitoring tools and relevant health products.
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
This page is for educational purposes only. It is not medical advice. Dapoxetine is not FDA-approved in the United States. In countries where it is approved, it requires a prescription. Do not combine dapoxetine with MAOIs, other SSRIs, triptans, or tramadol — serotonin syndrome risk is real and potentially life-threatening. Always consult a qualified physician before use.